查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024888

恒溫核酸增幅技術市場規模、佔有率、趨勢和預測：按產品、技術、應用、最終用戶和地區分類，2026-2034年

Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球恒溫核酸增幅技術市場規模為38億美元。展望未來，IMARC Group預測該市場將在2026年至2034年間以9.92%的複合年成長率成長，到2034年達到90億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過43.4%。快速準確診斷需求的成長、感染疾病的蔓延、攜帶式檢測設備的快速發展以及在醫療保健、食品安全和環境監測等領域的廣泛應用，再加上政府主導的各項舉措的大力支持，是推動恒溫核酸增幅技術市場佔有率成長的主要因素。

用於檢測感染疾病-19 的恒溫核酸增幅技術 (INAAT) 的持續發展是推動市場成長的關鍵因素之一。此外，全球人口老化、癌症和其他慢性疾病盛行率上升，以及對高效診斷和治療方法日益成長的需求，也促進了市場成長。預計未來 30 年，65 歲及以上老年人口將加倍，到 2050 年達到 16 億。此外，預計 2023 年美國將新增 1,958,310 例癌症病例和 609,820 例癌症相關死亡病例。這些成長趨勢正在推動對有效治療方法的需求。此外，用於擴增去氧核糖核酸(DNA) 和核糖核酸 (RNA)的恒溫環型核酸擴增的引入，以及基因改造生物 (GMO) 的鑑定，也推動了對 INAAT 的需求。

隨著國內外旅行的增加、都市化的加速以及環境的變化，美國面臨感染疾病爆發風險的加劇。結核病、西尼羅河病毒等疾病，以及茲卡病毒、屈公病等新出現的威脅，都凸顯了高效、全面的診斷工具的必要性。例如，美國今年報告了9,633例結核病病例，比2022年增加了15.6% 。恒溫核酸增幅技術已成為快速、準確地識別這些病原體的關鍵解決方案。該技術比傳統方法更快、更有效率，因為它無需熱循環即可檢測微量病原體。包括美國疾病管制與預防中心（CDC）在內的美國公共衛生機構正致力於推廣等溫診斷技術，以提高其及早發現和應對健康問題的能力。例如，在蚊媒疾病頻繁爆發的地區，這些診斷工具正被應用於更有效地監測和控制疫情。

恒溫核酸增幅技術市場趨勢：

對快速診斷解決方案的需求日益成長

感染疾病和基因檢測領域對更快、更準確、更經濟的診斷解決方案的需求日益成長，這將推動INAAT在全球的應用。與傳統的基於PCR的方法相比，INAAT無需複雜的循環設備即可快速獲得結果。因此，INAAT非常適合資源匱乏環境下的就地檢驗，以及應對諸如COVID-19疫情等突發公共衛生事件。

此外，慢性病和危及生命的疾病發生率不斷上升，推動了對更先進診斷技術的需求。例如，世界衛生組織（WHO）2022年2月的報告指出，癌症佔全球死亡人數的五分之一，凸顯了及時準確診斷的緊迫性。等溫核酸擴增技術（INAAT）是一種可靠的快速檢測方法，是疾病早期發現和管理中極為有效的工具，因此也促進了對恒溫核酸增幅技術的需求。

醫學和個人化醫療的進展

個人化醫療和分子診斷的發展趨勢顯著推動了對恒溫核酸增幅（INAAT）等先進檢測技術的需求。 INAAT能夠快速、經濟高效地檢測特定的基因突變、病原體或生物標記物，從而支持更具針對性的治療並改善醫療效果。隨著精準醫療的不斷發展，INAAT在提升診斷能力、確保及時介入和加速個人化治療方面發揮著至關重要的作用。

分子診斷在各種醫療環境中的日益普及推動了恒溫核酸增幅技術市場的成長。例如，2021年12月，美國Hologic公司發布了Panther Trax系統，可實現全自動化，滿足高通量檢測的需求。該系統已在美國、歐洲、加拿大、澳洲和紐西蘭上市，體現了醫療保健產業致力於利用先進技術獲得更有效率、更準確的診斷結果的決心。精準醫療不斷發展，等溫核酸擴增技術（INAAT）將在未來成為所有診斷和患者照護的核心。

技術創新及與攜帶式設備的整合

恒溫環型核酸擴增（HDA）等先進的等溫擴增技術提高了恒溫核酸增幅（INAAT）的靈敏度、特異性和便捷性。這些技術進步是進一步提升INAAT在各種診斷領域效用的關鍵。此外，攜帶式和手持式設備與INAAT技術的日益融合，拓寬了其在現場診斷中的應用範圍，使其能夠在偏遠地區、軍事環境和旅行相關的健康篩檢中高效進行檢測，從而促進了整體市場擴張。

全球日益成長的健康問題，包括癌症負擔的不斷加重，進一步推動了這項需求。國際癌症研究機構（IARC）在2020年12月的報告中指出，2020年全球新增癌症病例達1,930萬總合。如此高的發生率使得臨床和現場診斷都需要快速、有效率和準確的診斷方法。因此，INAAT在診斷中的作用至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：恒溫核酸增幅技術的全球市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 裝置
  • 試劑

第7章 市場區隔：依技術分類

  • 解旋酶依賴性擴增（HDA）
  • 切口酵素增殖反應（NEAR）
  • 恒溫環型核酸擴增（LAMP）
  • 鏈替換擴增（SDA）
  • 核酸序列擴增（NASBA）
  • 轉錄媒介增幅（TMA）
  • 單引子等溫擴增（SPIA）
  • 其他

第8章 市場區隔：依應用領域分類

  • 感染疾病診斷
    • 主要類型
      • 肝炎
      • CT/NG
      • HIV
      • 流感
      • 其他
  • 血液篩檢
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷檢查室
  • 研究所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Eiken Chemical Co. Ltd.
    • Genomtec
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • OptiGene Limited
    • Qiagen NV
    • QuidelOrtho Corporation
    • Thermo Fisher Scientific Inc.
    • Ustar Biotechnologies
Product Code: SR112026A2205

The global isothermal nucleic acid amplification technology market size was valued at USD 3.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 9.0 Billion by 2034, exhibiting a CAGR of 9.92% during 2026-2034. North America currently dominates the market, holding a market share of over 43.4% in 2025 . The rising demand for fast and accurate diagnostics, increasing prevalence of infectious diseases, rapid advancements in portable testing devices, and expanding applications across healthcare, food safety, and environmental monitoring, with strong support from government initiatives are major factors boosting the isothermal nucleic acid amplification technology market share.

The ongoing development in isothermal nucleic acid amplification technology (INAAT) for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the isothermal nucleic acid amplification technology market growth. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. The population of individuals aged 65 and older is anticipated to double in the next 30 years, reaching 1.6 billion by 2050. Additionally, it was projected that in 2023, the United States would experience 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths. These increased rates have heightened the demand for effective treatment options. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT.

With increasing domestic and international travel, urbanization, and environmental changes, the United States is facing a growing risk of infectious disease outbreaks. Diseases such as tuberculosis, West Nile virus, and emerging threats like Zika and chikungunya have highlighted the need for efficient and widespread diagnostic tools. For instance, the United States reported 9,633 cases of tuberculosis (TB) disease in the year, which is a 15.6% hike in comparison with 2022. Isothermal nucleic acid amplification technology has become a vital solution for identifying these pathogens rapidly and accurately. This technology's ability to detect even low levels of pathogens without requiring thermal cycling makes it faster and more efficient than traditional methods. U.S. public health organizations, including the Centers for Disease Control and Prevention (CDC), are focusing on isothermal diagnostics to improve their ability to detect and respond to health issues at an earlier stage. For instance, regions with frequent mosquito-borne disease activity are adopting these diagnostic tools to monitor and control outbreaks more effectively.

ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET TRENDS:

Increased Demand for Rapid Diagnostic Solutions

The increasing need for faster, more accurate, and cost-effective diagnostic solutions for infectious diseases and genetic testing will be the impetus for widespread adoption of INAAT globally. In contrast to traditional PCR-based methods, INAAT offers quick results without demanding the use of complex thermal cycling equipment. Hence, INAAT is highly amenable to point-of-care testing in resource-poor settings as well as the management of public health emergencies like the COVID-19 pandemic.

In addition, increased incidence of chronic and life-threatening diseases is creating an added demand for improved diagnostic technologies. For example, a World Health Organization report of February 2022 cited that cancer was responsible for one-fifth of global deaths, showing the urgency in providing timely, accurate diagnostics. INAAT being a reliable process for fast delivery is an invaluable tool for detection at early stages and management of disease, therefore, fueling the isothermal nucleic acid amplification technology market demand.

Advancements in Healthcare and Personalized Medicine

The rising trend of personalized medicine and molecular diagnostics is highly fueling the need for advanced testing technologies like Isothermal Nucleic Acid Amplification Technology (INAAT). INAAT enables the rapid and cost-effective detection of specific genetic mutations, pathogens, or biomarkers, which support more targeted treatments and improved healthcare outcomes. As precision medicine continues to gain momentum, INAAT is playing a critical role in enhancing diagnostic capabilities, ensuring timely interventions, and facilitating customized therapies.

The growing use of molecular diagnostics across different healthcare settings is contributing to the growth of the isothermal nucleic acid amplification technology market. For instance, in December 2021, Hologic, Inc. (US) introduced the Panther Trax system, which provides full automation to accommodate the demands of high-volume testing. This system, commercially available in the US, Europe, Canada, Australia, and New Zealand, reflects the commitment of the healthcare sector toward using advanced technologies for more efficient and accurate diagnostic results. As it is, precision medicine continues to evolve, and INAAT will be the heart of all diagnostics and patient care in the future.

Technological Innovations and Integration with Portable Devices

Recent isothermal amplification techniques, such as Loop-mediated Isothermal Amplification (LAMP) and Helicase-Dependent Amplification (HDA), have enhanced the sensitivity, specificity, and convenience of Isothermal Nucleic Acid Amplification Technology (INAAT). These technological advancements are the key to furthering INAAT's utility in different fields of diagnostics. Furthermore, the advancement of integration of portable, handheld devices with INAAT has widened its applications in field diagnostics, and thus, efficient testing in remote areas, military settings, and travel-related health screenings is hence contributing to the market expansion as a whole.

Further fueling this requirement is the surging global health concerns such as the cancer burden, which continues to increase over time. IARC has documented in its December 2020 report that a total of 19.3 million new cancer cases occurred across the world in 2020. Such prevalence calls for a rapid, efficient, and precise diagnostic method to be in both clinical and field diagnostic environments; thus, the role of INAAT in diagnostics becomes a fundamental one.

ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY INDUSTRY SEGMENTATION:

Analysis by Product:

  • Instruments
  • Reagents

As per the isothermal nucleic acid amplification technology market forecast, reagents hold the majority of the isothermal nucleic acid amplification technology market share with 62.7%, driven by their critical role in enabling accurate and efficient amplification processes. These include primers, enzymes, nucleotides, and buffers, which are essential for ensuring reliable diagnostic outcomes. The growing demand for point-of-care (POC) testing and rapid diagnostics has fueled the consumption of reagents, as they are vital for tests targeting infectious diseases, genetic disorders, and oncology biomarkers. Additionally, the increased adoption of isothermal technologies in research settings and diagnostic labs has amplified the need for high-quality and customizable reagents tailored to specific applications.

Analysis by Technology:

  • Helicase-Dependent Amplification (HDA)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Strand Displacement Amplification (SDA)
  • Nucleic Acid Sequence-Based Amplification (NASBA)
  • Transcription Mediated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Others

Based on the isothermal nucleic acid amplification technology market outlook, transcription mediated amplification (TMA) accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time. Its great sensitivity, quick processing, and direct RNA target amplification are other factors contributing to its expansion. Because TMA yields reliable findings even with low pathogen loads, it is often employed in clinical diagnostics, especially for the detection of infectious illnesses including HIV, hepatitis, and respiratory infections. Compared to conventional processes, it is quicker and more economical since its isothermal nature removes the need for heat cycling. Its market leadership is further supported by the technology's increasing use in molecular diagnostics and its shown dependability in extensive screening programs, particularly for STIs.

Analysis by Application:

  • Infectious Disease Diagnosis
    • Hepatitis
    • CT/NG
    • HIV
    • Influenza
    • Others
  • Blood Screening

Due to the pressing requirement for quick and precise pathogen identification, infectious disease diagnosis holds a major market share of 35.7%. There is a greater need for this technology for early diagnosis and efficient treatment due to the rising incidence of illnesses including tuberculosis, HIV, hepatitis, and respiratory infections. It has proven invaluable in public health emergencies due to its capacity to provide trustworthy outcomes at point of care settings and environments with limited resources. Supported by investments in diagnostics and government-led efforts to increase healthcare accessibility, this category continues to dominate due to persistent worldwide concerns about new infectious illnesses and the need for improved disease monitoring.

Analysis by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories

Based on the isothermal nucleic acid amplification technology market trends, hospitals presently dominate the market with 40.0% share, due to their critical role in diagnosing and managing a wide range of diseases. These facilities frequently use the technology for its rapid turnaround time and high accuracy, which are essential for emergency cases, infectious disease management, and preoperative evaluations. Hospitals are also primary points for large-scale disease screening programs and play a significant role in epidemic and pandemic responses. The availability of trained professionals and advanced infrastructure in hospitals further enhances the adoption of these technologies, making them central to modern healthcare diagnostics.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America exhibits a clear dominance in the market with a share of 43.4%, driven by advanced healthcare infrastructure, strong investment in research and development, and the high prevalence of infectious diseases such as influenza, HIV, and hepatitis. The United States, in particular, leads the region due to its early adoption of innovative diagnostic technologies and significant funding from government bodies like the NIH and CDC to combat public health challenges. The region also benefits from the presence of key market players and a well-established regulatory framework that supports the rapid commercialization of diagnostic solutions. Furthermore, the increasing demand for point-of-care testing and personalized medicine is boosting market growth in North America.

KEY REGIONAL TAKEAWAYS:

UNITED STATES ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET ANALYSIS

The rising prevalence of chronic diseases in the United States is a significant factor driving the expansion of the isothermal nucleic acid amplification technology (INAAT) market. According to the CDC's 2024 report, about 157 million Americans were living with chronic diseases in 2020, and 81 million had multiple conditions. The growing burden of chronic diseases, which often require regular and accurate diagnostic testing, has created a pressing need for efficient and accessible diagnostic technologies. INAAT, offering rapid, cost-effective, and easy-to-use testing without complex thermal cycling equipment, is well-positioned to address this demand. It will be an imperative requirement in early detection and management of chronic diseases that INAAT solutions provide quicker results for genetic mutations, pathogens, and biomarkers. The growth of frequent and accurate testing for the management of disease is on the rise. Combined with the shift toward point-of-care testing, this trend further accelerates the growth of the INAAT solution market. With an increase in chronic conditions prevalent in the United States, INAAT technologies will drive the market with great influence.

EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET ANALYSIS

The increasing incidence of cancer within the European Union is a key factor propelling the growth of the isothermal nucleic acid amplification technology (INAAT) market. New cancer cases in the EU have increased by 2.3% from 2020 to 2.74 million in 2022, according to industry reports. As cancer detection and management are becoming increasingly important, there is a growing demand for advanced diagnostic tools that provide quick and accurate results. Improvement in the efficiency and affordability with which INAAT detects specific genetic mutations and biomarkers is the way forward for improved cancer diagnostics. The point-of-care testing device, in that regard, holds a special significance for areas not well-equipped to access high-technology laboratories. The speed with which INAAT can provide correct results without involving complex equipment enhances its value immensely in the case of early diagnosis of cancer-a major determinant of proper treatment. This, again, will accelerate the market's growth as it is going to increase INAAT technology adoption because of a steady rise in Europe's cancer burden.

ASIA PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET ANALYSIS

The rising incidence of breast and cervical cancer in the Asia-Pacific region is a primary driver of growth for the Isothermal Nucleic Acid Amplification Technology (INAAT) market. According to the World Economic Forum's 2023 report, the number of breast cancer cases in the region is expected to increase by 21%, and cervical cancer incidence is projected to increase by 19%. This increased cancer burden requires advanced and rapid diagnostic solutions that can improve early detection and treatment outcomes. With its delivery of accurate, timely results regarding genetic mutations, pathogens, and biomarkers, INAAT becomes increasingly important for cancer diagnostics. The integration of the technology into portable, user-friendly devices adds to its importance in resource-poor areas and the Asia-Pacific region. By enabling faster and cost-effective testing without the necessity of complex laboratory equipment, INAAT is going to help satisfy the increasing need for efficient diagnostic solutions, hence contributing to market growth in the region.

LATIN AMERICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET ANALYSIS

The rising cancer burden in Latin America is the main growth driver for the INAAT market. Industry reports indicate that the Asia-Pacific region experiences around 1.5 million new cancer cases and 700,000 cancer-related deaths each year. This trend shows an alarming rate, which emphasizes the need for efficient and rapid diagnostic solutions that may enhance early detection and improve treatment outcomes. INAAT offers tremendous advantages in cancer diagnostics by providing rapid, accurate, and cost-effective testing for genetic mutations, biomarkers, and pathogens. The technology's ability to deliver results quickly without the need for complex thermal cycling equipment makes it highly suitable for point-of-care testing, especially in regions with limited healthcare infrastructure. As the number of cancer cases keeps growing in LAC, INAAT is ready to take up the role that will be supportive of early detection of cancer and personalized medicine to drive the market growth in this region.

MIDDLE EAST AND AFRICA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET ANALYSIS

According to an industry report, Saudi Arabia recorded 17.4 percent Y-Y growth to 2023 as its significant hike in the outlay towards Research and development reaching SR 22.61 Billion (USD 6.02 Billion), would be another turning point driving in the development across the MEA Isothermal Nucleic Acid Amplification Technology (INAAT) marketplace. As the need for quick and sensitive diagnostics continues to rise, especially for infectious diseases and genetic testing, the ability of INAAT to deliver fast, affordable, and efficient testing without complex thermal cycling equipment is finding favor. This investment is most likely to enhance innovations and infrastructures in health care, therefore promoting INAAT in the region. In addition, Saudi Arabia focuses on enhancing the capabilities of its healthcare system, aligning with broader goals in MEA, namely improving diagnostic accuracy and accessibility. Therefore, INAAT will contribute to the development of the market in the region, which in turn will assist in addressing regional healthcare challenges.

COMPETITIVE LANDSCAPE:

Major players are strengthening their positions by concentrating on innovation, strategic alliances, and regional growth. To satisfy the increasing need for quick and precise diagnosis, businesses are launching sophisticated diagnostic systems with increased sensitivity, mobility, and usability. Numerous businesses are making significant investments in research and development (R&D) to provide next-generation technologies specifically suited for use in genetic testing, cancer, and infectious disease diagnostics. Through strategic collaborations with governments, non-governmental organizations, and healthcare providers, these businesses are extending their reach into developing countries and environments with limited resources. Partnerships to provide low-cost diagnostic services in underprivileged areas, for example, have also accelerated. Additionally, a number of participants are improving data sharing and real-time monitoring by utilizing digital technologies including cloud-based platforms and smartphone connection.

The report provides a comprehensive analysis of the competitive landscape in the isothermal nucleic acid amplification technology market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • Eiken Chemical Co. Ltd.
  • Genomtec
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • OptiGene Limited
  • Qiagen NV
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Isothermal Nucleic Acid Amplification Technology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of Covid-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Helicase-Dependent Amplification (HDA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Nicking Enzyme Amplification Reaction (NEAR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Loop-Mediated Isothermal Amplification (LAMP)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Strand Displacement Amplification (SDA)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nucleic Acid Sequence-Based Amplification (NASBA)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcription Mediated Amplification (TMA)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Single Primer Isothermal Amplification (SPIA)
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 Hepatitis
      • 8.1.2.2 CT/NG
      • 8.1.2.3 HIV
      • 8.1.2.4 Influenza
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Blood Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Eiken Chemical Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Genomtec
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Hologic Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Meridian Bioscience Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 OptiGene Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Qiagen NV
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 QuidelOrtho Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Ustar Biotechnologies
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Isothermal Nucleic Acid Amplification Technology (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Isothermal Nucleic Acid Amplification Technology (Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Isothermal Nucleic Acid Amplification Technology (Helicase-Dependent Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Isothermal Nucleic Acid Amplification Technology (Nicking Enzyme Amplification Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Isothermal Nucleic Acid Amplification Technology (Loop-Mediated Isothermal Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Isothermal Nucleic Acid Amplification Technology (Strand Displacement Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Isothermal Nucleic Acid Amplification Technology (Nucleic Acid Sequence-Based Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Isothermal Nucleic Acid Amplification Technology (Transcription Mediated Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Isothermal Nucleic Acid Amplification Technology (Single Primer Isothermal Amplification) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Isothermal Nucleic Acid Amplification Technology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Isothermal Nucleic Acid Amplification Technology (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Isothermal Nucleic Acid Amplification Technology (Blood Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Isothermal Nucleic Acid Amplification Technology (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Isothermal Nucleic Acid Amplification Technology (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Isothermal Nucleic Acid Amplification Technology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Isothermal Nucleic Acid Amplification Technology (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Isothermal Nucleic Acid Amplification Technology (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: North America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: North America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: United States: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: United States: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Canada: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Canada: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Asia Pacific: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: China: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: China: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Japan: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Japan: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: India: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: India: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: South Korea: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: South Korea: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Australia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Australia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Indonesia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Indonesia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Europe: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Europe: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Germany: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Germany: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: France: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: France: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: United Kingdom: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Italy: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Italy: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Spain: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Spain: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Russia: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Russia: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Latin America: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Latin America: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Brazil: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Brazil: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Mexico: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Mexico: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Middle East and Africa: Isothermal Nucleic Acid Amplification Technology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Global: Isothermal Nucleic Acid Amplification Technology Industry: SWOT Analysis
  • Figure 92: Global: Isothermal Nucleic Acid Amplification Technology Industry: Value Chain Analysis
  • Figure 93: Global: Isothermal Nucleic Acid Amplification Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Isothermal Nucleic Acid Amplification Technology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Isothermal Nucleic Acid Amplification Technology Market: Competitive Structure
  • Table 8: Global: Isothermal Nucleic Acid Amplification Technology Market: Key Players